Yahoo
Shenzhen - Delayed Quote CNY

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ)

28.93 -0.09 (-0.31%)
At close: November 6 at 3:04:30 PM GMT+8
Chart Range Bar
Loading chart for 002223.SZ
  • Previous Close 29.02
  • Open 27.52
  • Bid 28.93 x --
  • Ask 28.94 x --
  • Day's Range 28.41 - 29.60
  • 52 Week Range 23.90 - 46.31
  • Volume 18,762,504
  • Avg. Volume 10,660,382
  • Market Cap (intraday) 28.775B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 25.16
  • EPS (TTM) 1.15
  • Earnings Date --
  • Forward Dividend & Yield 1.20 (4.15%)
  • 1y Target Est 34.28
  • Moby Rating Neutral

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. provides medical devices and health product in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monitors, oximeters, and thermometers; wheelchairs; AEDs; and traditional Chinese medicine product solutions. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is based in Danyang, China.

www.yuyue.com.cn

6,676

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002223.SZ
21.40%
SSE Composite Index (000001.SS)
8.05%

1-Year Return

002223.SZ
14.21%
SSE Composite Index (000001.SS)
8.95%

3-Year Return

002223.SZ
1.86%
SSE Composite Index (000001.SS)
19.32%

5-Year Return

002223.SZ
6.83%
SSE Composite Index (000001.SS)
4.51%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 2.04B
Earnings 288.48M
Profit Margin 14.13%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
2B
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

31.04
34.28 Average
28.93 Current
37.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.30%

  • Return on Assets (ttm)

    3.25%

  • Return on Equity (ttm)

    8.69%

  • Revenue (ttm)

    8.02B

  • Net Income Avi to Common (ttm)

    1.15B

  • Diluted EPS (ttm)

    1.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.37B

  • Total Debt/Equity (mrq)

    0.18%

  • Levered Free Cash Flow (ttm)

    -4.22B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: